Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Delaloge, S

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar 2001 - 1248-55 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study

0732-183X

10.1200/JCO.2001.19.5.1248 doi


Adolescent
Adult
Aged
Antineoplastic Agents, Alkylating--adverse effects
Bone Neoplasms--drug therapy
Dioxoles--adverse effects
Disease Progression
Female
Humans
Isoquinolines--adverse effects
Liver--drug effects
Male
Middle Aged
Neutropenia--chemically induced
Sarcoma--drug therapy
Tetrahydroisoquinolines
Trabectedin
Treatment Outcome